fluorescein-5-isothiocyanate has been researched along with lactobionic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MC; Chiu, YL; Huang, MF; Mi, FL; Shyu, SS; Sung, HW; Wu, YY; Yu, SH | 1 |
| Chang, C; Chen, CS; Cheng, SX; Jiang, XJ; Lu, B; Wang, T; Wu, DQ; Zhang, XZ; Zhang, YY; Zhuo, RX | 1 |
| Cheng, HW; Huang, FW; Li, C; Xue, ZY; Zhang, J; Zhang, XZ; Zhuo, RX | 1 |
| Cai, K; Duan, L; Hu, Y; Liu, P; Luo, Z; Yang, W; Zhao, L | 1 |
| Chen, L; Chen, X; He, C; Yao, X; Zhang, Z | 1 |
| Altamura, E; Azzariti, A; Cutrignelli, A; Denora, N; Di Fonte, R; Franco, M; Iacobazzi, RM; Laquintana, V; Lopalco, A; Lopedota, AA; Porcelli, L | 1 |
6 other study(ies) available for fluorescein-5-isothiocyanate and lactobionic acid
| Article | Year |
|---|---|
Synthesis of a novel glycoconjugated chitosan and preparation of its derived nanoparticles for targeting HepG2 cells.
Topics: Cell Line, Tumor; Chitosan; Disaccharides; Fluorescein-5-isothiocyanate; Galactose; Humans; Ligands; Macromolecular Substances; Magnetic Resonance Spectroscopy; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Models, Chemical; Nanoparticles; Spectrometry, Fluorescence | 2007 |
Galactosylated fluorescent labeled micelles as a liver targeting drug carrier.
Topics: Anti-Inflammatory Agents; Biocompatible Materials; Cell Line; Dextrans; Disaccharides; Drug Carriers; Drug Delivery Systems; Ethylenediamines; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Galactose; Humans; Liver; Materials Testing; Micelles; Molecular Structure; Particle Size; Polymers; Prednisone; Tissue Distribution | 2009 |
Fabrication of lactobionic-loaded chitosan microcapsules as potential drug carriers targeting the liver.
Topics: Alkynes; Azides; Calcium Carbonate; Capsules; Cell Adhesion; Chitosan; Click Chemistry; Disaccharides; Drug Carriers; Fluorescein-5-isothiocyanate; Hep G2 Cells; Humans; Liver; Magnetic Resonance Spectroscopy; Microscopy, Confocal; Microscopy, Electron, Transmission; Organ Specificity; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared | 2011 |
Mesoporous silica nanoparticles end-capped with collagen: redox-responsive nanoreservoirs for targeted drug delivery.
Topics: Collagen; Disaccharides; Drug Carriers; Endocytosis; Fluorescein-5-isothiocyanate; Hep G2 Cells; Humans; Nanoparticles; Oxidation-Reduction; Porosity; Silicon Dioxide | 2011 |
Fabrication of modular multifunctional delivery for antitumor drugs based on host-guest recognition.
Topics: Antineoplastic Agents; Benzimidazoles; beta-Cyclodextrins; Cell Death; Cell Proliferation; Dextrans; Disaccharides; Doxorubicin; Drug Delivery Systems; Drug Liberation; Flow Cytometry; Fluorescein-5-isothiocyanate; Folic Acid; HeLa Cells; Hep G2 Cells; Humans; Intracellular Space; Micelles; Proton Magnetic Resonance Spectroscopy; Spectrometry, Fluorescence | 2015 |
Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers.
Topics: Asialoglycoprotein Receptor; Dendrimers; Disaccharides; Drug Carriers; Fluorescein-5-isothiocyanate; Hep G2 Cells; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Sorafenib | 2017 |